Automated insulin delivery for type 1 diabetes
Part of Hormones & metabolism, Immune system & allergy clinical trials.
This trial tests a new automated insulin delivery system (APGO algorithm) to see how well it controls blood sugar and if it's safe. It may help people with type 1 diabetes manage their condition more easily.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have type 1 diabetes.
- You have had diabetes for at least 1 year.
- You are 18 years old or older.
- You are willing to follow the study rules and sign a consent form.
- You are not pregnant, breastfeeding, or planning to become pregnant.
- You are not taking any medicines that affect your body's sugar (carbohydrate) processing.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new automated insulin delivery (AID) system that connects your insulin pump to your glucose monitor to help keep your blood sugar in range. It is for both children and adults with type 1 diabetes who have not used an AID system before.
This trial is testing a new automated insulin pump system that talks to your smartphone and lets the care team check on you from home. It helps people with type 1 diabetes better manage their blood sugar without extra trips to the clinic.
This trial tests a hybrid closed-loop system that automatically adjusts insulin delivery. It may help you manage your blood sugar more easily if you currently give yourself daily insulin shots.
This study tests a new automated insulin delivery system to help people with type 1 diabetes better manage their blood sugar. It aims to see if the system improves glucose control safely.
This study is testing whether an automated insulin delivery system (often called an artificial pancreas) can help adults who have just been diagnosed with type 1 diabetes manage their blood sugar levels. It aims to improve long-term control and make day-to-day management easier.
This trial tests a new experimental automated insulin delivery system (a type of 'artificial pancreas') to see if it is safe and works better than current systems. It may help people whose blood sugar is not well controlled with their current pump or system.
Hear when a new Diabetes Mellitus Type 1 trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.